Vaccines - Turkmenistan

Turkmenistan

in Turkmenistan, a country Central_Asia, is expected to experience significant growth in the Vaccines market.
By 2024, revenue in this market is projected to reach US$28.79m.
This impressive figure demonstrates the potential for economic expansion in the country's healthcare sector.
Furthermore, it is anticipated that the Vaccines market in Turkmenistan will continue to flourish, with an annual growth rate (CAGR 2024-2029) of 3.11%.
This steady growth trajectory is predicted to result in a market volume of US$33.56m by 2029.
These numbers highlight the increasing demand for vaccines and the importance placed on healthcare in Turkmenistan.
In a global comparison, it is noteworthy that United States is expected to generate the highest revenue in the Vaccines market, reaching a staggering US$29,120.00m in 2024.
This showcases the dominance of the United States in this particular market, but also emphasizes the potential for growth and development in other countries, including in Turkmenistan.
Turkmenistan is actively investing in research and development for domestic vaccine production to enhance its self-sufficiency in the healthcare sector.

Key regions: Australia, Italy, France, South Korea, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

Turkmenistan, a country located in Central Asia, has been experiencing a steady growth in its vaccines market.

Customer preferences: The demand for vaccines in Turkmenistan has been increasing in recent years due to the government's focus on improving its healthcare system. The population is becoming more aware of the importance of preventative healthcare measures, and as a result, there is a growing interest in vaccination.

Trends in the market: Turkmenistan's vaccines market is primarily driven by the demand for routine immunizations, such as those for measles, mumps, and rubella. Additionally, there has been an increase in demand for vaccines that protect against infectious diseases such as hepatitis B and meningococcal disease. The government's efforts to improve the healthcare system have also led to an increase in the availability of vaccines in the country.

Local special circumstances: One of the unique factors in the vaccines market in Turkmenistan is the government's role in providing healthcare to its citizens. The government has made significant investments in the healthcare system, including the construction of new hospitals and clinics, and the provision of free healthcare to all citizens. This has helped to increase access to vaccines in the country.

Underlying macroeconomic factors: Turkmenistan's economy is heavily dependent on its natural gas reserves, which account for the majority of the country's exports. The government's focus on developing the healthcare system is part of a broader effort to diversify the economy and reduce its reliance on natural gas. As a result, there has been an increase in government spending on healthcare, which has helped to drive growth in the vaccines market. Additionally, Turkmenistan's strategic location as a transit hub for trade between Asia and Europe has helped to attract investment in the healthcare sector.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.